Droperidol

氟哌利多

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameDroperidol
Drug Alias Namedroperidol氟派利多哒哌啶醇droperidolum氟哌啶 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsVomitingNauseaPostoperative Nausea and Vomiting +[4] 
Global Approved IndicationsVomitingNauseaHyperemesis Gravidarum
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryUnited States
Original Approved Date1970/06/11
Country/TerritoryUnited StatesBrazilMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesXi'An Libang Pharmaceutical Co Ltd
Inactive CompaniesRising Pharma Holdings IncInstituto Do Cancer Do Estado De São Paulo
Active IndicationsHyperemesis Gravidarum
Inactive IndicationsVomitingNauseaPostoperative Nausea and Vomiting

Other Information

ATC CodeN05AD08
Related LinksWikipediaDrugBankKEGG